Genetic basis of systemic lupus erythematosus

Drugs of Today

Volumn 38, Issue 3, 2002, Pages 167-184

  Hirose, Sachiko ^a   Jiang, Yi ^a   Hamano, Yoshitomo ^a   Nishimura, Hiroyuki ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNITY; AUTOSOMAL INHERITANCE; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENOME ANALYSIS; HISTOPATHOLOGY; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR GENETICS; MULTIGENE FAMILY; NONHUMAN; REVIEW; STRAIN DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS; ALLELE; ANIMAL; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; GENOME; IMMUNOLOGY; MOUSE; MOUSE STRAIN; MURPHY ROTHS LARGE LYMPHOPROLIFERATIVE MOUSE;

ALLELES; ANIMAL; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HUMAN; LINKAGE (GENETICS); LUPUS ERYTHEMATOSUS, SYSTEMIC; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MICE, INBRED MRL LPR; MICE, INBRED STRAINS; ANIMALS; HUMANS;

EID: 0036225886     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2002.38.3.820125     Document Type: Review

References (134)

1. Genetic studies of human lupus in families
2. Studies of twins with systemic lupus erythematosus: A review of the literature and presentation of 12 additional sets
3. Complex traits
4. The epidemiology of systemic lupus erythematosus
5. Genetic analysis of autoimmune disease
6. The application of genetic epidemiology to systemic lupus erythematosus
7. Genetic susceptibility to lupus nephritis
8. A revised estimate of twin concordance in systemic lupus erythematosus
9. Serological studies of monozygotic twins with systemic lupus erythematosus
10. Threshold characters
11. Redecha A novel polymorphism of FcgammaRIIIa(CD16) alters receptor function and predisposes to autoimmune disease
12. Schachter FcgRIIA alleles are heritable risk factors for lupus nephritis in African Americans
13. Lincoln A genetic map of the mouse suitable for typing intraspecific crosses
14. Kalunian evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus
15. Salmon Genome scan of human systemic lupus erythematosus: Evidence for linkage on chromosome 1q in African-American pedigrees
16. Gaffney Genome scan of human systemic lupus erythematosus by regression modeling: Evidence of linkage and epistasis at 4p16-15.2
17. A genome-wide search for susceptibility genes in human systemic lupus erythematosus sibpair families
18. Selby Genome screening in human systemic lupus erythematosus: Results from a second Minnesota cohort and combined analysis of 187 sibpair families
19. Johanneson A susceptibility locus for human systemic lupus erythematosus (hSLE1) on chromosome 2q
20. Li genomewide screen for systemic lupus erythematosus susceptibility genes in multiplex families
21. Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results
22. Grossman PARP alleles within the linked chromosomal region are associated with systemic lupus erythematosus
23. Gaffney PARP alleles and SLE: Failure to confirm association with disease susceptibility
24. Gaffney Genetic linkage and transmission disequilibrium of marker haplotypes at chromosome 1q41 in human systemic lupus erythematosus
25. Association of HLA-DR2/DR4 heterozygosity with systemic lupus erythematosus in Japanese patients
26. Presence of anti-SM reactivity in autoimmune mouse strains
27. (SWR × SJL) F1 mice: A new model of lupus-like disease
28. Genetic association between natural autoantibody responses to histones and DNA in murine lupus
29. Okada Immunology and immunopathology of the autoimmune disease of NZB and related mouse strains
30. The "Ly-1 B" cell subpopulation in normal, immunodefective, and autoimmune mice
31. The Ly-1 B cells lineage
32. Renal disease associated with positive lupus erythematosus tests in a cross-bred strain of mice
33. z homozygous inbred strains of mice derived from New Zealand Black and New Zealand White mice: Origins and initial characterization
34. Autoimmunity and lymphoproliferation: Induction by mutant gene lpr, and acceleration by a male-associated factor in strain BXSB mice
35. Copeland Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediate apoptosis
36. Abnormalities induced by the mutant gene lpr: Expression of unique lymphocyte subsets
37. Genetic basis of complex pathological manifestations of collagen disease: Lessons from MRL/lpr and related mouse models
38. A new mutation, gld, that produces lymphoproliferation and autoimmunity in C3H/HeJ mice
39. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand
40. Phenotypic, functional, and molecular genetic comparisons of the abnormal lymphoid cells of C3H-lpr/lpr and C3H-gld/gldmice
41. lpr and gld single gene models of systemic autoimmunity and lymphoproliferative disease
42. Induction of various autoantibodies by mutant gene lpr in several strains of mice
43. (NZW × BXSB) F1 hybrid; a model of acute lupus and coronary vascular disease with myocardial infarction
44. (NZW × BXSB)F1 mouse; a new animal model of idiopathic thrombocytopenic purpura
45. Ichikawa Anticardiolipin antibodies in NZW × BXSB F1 mice: A model of antiphospholipid syndrome
46. The anticardiolipin syndrome
47. Lessons from BXSB and related mouse models
48. Mutation in Fas associated with human lymphoproliferative syndrome and autoimmunity
49. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome
50. The genetic contribution of the NZB mouse to the renal disease of the NZB × NZW hybrid
51. Three genes for lupus nephritis in NZB × NZW mice
52. The contribution of NZW genes to lupus-like diseases in (NZB × NZW)F1 mice
53. T-cell-receptor-beta and I-A-beta-chain genes of normal SWR mice are linked with the development of lupus nephritis in NZB × SWR crosses
54. Polygenic control of susceptibility to murine systemic lupus erythematosus
55. Genetic studies of autoimmunity in New Zealand mice. III. Associations among anti-DNA antibodies, NTA, and renal disease in (NZB × NZW) F1 × NZW backcross mice
56. Sekita Genetic regulation of the class conversion of dsDNA-specific antibodies in (NZB × NZW) F1 hybrid
57. Genetic studies of autoimmunity in New Zealand mice. IV. Contribution of NZB and NZW genes to the spontaneous occurrence of retroviral gp70 immune complexes in (NZB × NZW) F1 hybrid and the correlation to renal disease
58. Sekigawa Enhancing effect of H-2-linked NZW gene(s) on the autoimmune traits of (NZB × NZW) F1 mice
59. Naturally occurring antibody response to DNA is associated with the response to retroviral gp70 in autoimmune New Zealand mice
60. Requirement of H-2 heterozygosity for autoimmunity in (NZB × NZW)F1 hybrid mice
61. Yoshida genetic studies on the skin lupus band test in New Zealand mice
62. 2bm12 mice
63. Lupus susceptibility loci in New Zealand mice
64. Backcross analysis of genes linked to autoantibody production in New Zealand White mice
65. Genetic linkage of IgG autoantibody production in relation to lupus nephritis in New Zealand hybrid mice
66. Control of multiple autoantibodies linked with a lupus nephritis susceptibility locus in New Zealand black mice
67. Heterozygosity of the major histocompatibility complex controls the autoimmune disease in (NZW × BXSB) F1 mice
68. The Yaa gene abrogates the major histocompatibility complex association of murine lupus in (NZB × BXSB) F1 hybrid mice
69. Multigenic control of lupus-associated anti-phospholipid syndrome in a model of (NZW × BXSB) F1 mice
70. Effect of major histocompatibility complex on autoimmune disease of H-2-congenic New Zealand mice
71. Influence of allelic polymorphism on the assembly and surface expression of class II MHC (Ia) molecules
72. MHC class II gene polymorphism of New Zealand mice and its possible contribution to autoimmunity
73. MHC heterozygosity and autoimmunity
74. z on autoimmune disease in New Zealand mice
75. d class II molecule in (NZB × NZW) F1 mice
76. + T-cell clones
77. The E-linked subregion of the major histocompatibility complex down-regulates autoimmunity in NZB × NZW F1 mice
78. d transgenic MHC haplotype-dependent
79. Human major histocompatibility complex contain a minimum of 19 genes between the complement cluster and HLA-B
80. A polymorphic microsatellite in the tumor necrosis factor alpha promoter identifies an allele unique to NZW mouse strain
81. Tumor necrosis factor-alpha in murine autoimmune 'lupus' nephritis
82. Tumor necrosis factor alpha in murine systemic lupus erythematosus disease models: Implications for genetic predisposition and immune regulation
83. Dissection of the effects of tumor necrosis factoralpha and class II gene polymorphisms within the MHC on murine systemic lupus erythematosus (SLE)
84. Multiple lupus susceptibility loci map to chromosome 1 in BXSB mice
85. Genetically determined aberrant down-regulation of FcgammaRIIB1 in germinal center B cells associated with hyper-IgG and IgG autoantibodies in murine systemic lupus erythematosus
86. Genetic determinants of autoimmune disease and coronary vasculitis in the MRL-lpr/lpr mouse model of systemic lupus erythematosus
87. Host modifier genes affect mouse auto-immunity induced by the lpr gene
88. Genetic aspects of inherent B-cell abnormalities associated with SLE and B-cell malignancy: Lessons from New Zealand mouse models
89. Susceptibility alleles for aberrant B- 1 cell proliferation involved in spontaneously occurring B-cell chronic lymphocytic leukemia in a model of New Zealand white mice
90. Mapping of a gene for hypergammaglobulinemia to the distal region on chromosome 4 in NZB mice and its contribution to systemic lupus erythematosus in (NZB × NZW)F1 mice
91. Mapping of a gene for the increased susceptibility of B 1 cells to Mott cell formation in murine autoimmune disease
92. Loci predisposing to autoimmunity in MRL-Fas lpr and C57BL/6-Fas lpr mice
93. Multiplex inheritance of component phenotypes in a murine model of lupus
94. Epistatic modifiers of autoimmunity in a murine model of lupus nephritis
95. Does the deletion within T cell receptor beta chain gene of NZW mice contribute to autoimmunity in (NZB × NZW) F1 mice?
96. Contribution of the gene linked to the T cell receptor beta chain gene complex of NZW mice to the autoimmunity of (NZB × NZW)F1 mice
97. Genetic analysis of MRL-lpr mice: Relationship of the FAS apoptosis gene to disease manifestations and renal disease-modifying loci
98. Genetic susceptibility to systemic lupus erythematosus
99. Linkage of a major quantitative trait locus to Yaa gene-induced lupus-like nephritis in (NZW × C57BL/6) F1 mice
100. Genetic analysis of the NZB contribution to lupus-like autoimmune disease in (NZB × NZW) F1 mice
101. Identification of intervals on chromosomes 1, and 13 linked to the development of lupus in BXSB mice
102. Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicit autoimmune disease
103. CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity
104. An immunological renal disease in transgenic mice that overexpress Fli-1, a member of the ets family of transcription factor genes
105. Anti-nuclear autoantibodies and lupus nephritis in transgenic mice expressing interferon gamma in the epidermis
106. Constitutive expression of interleukin(IL)-4 in vivo cause autoimmune-type disorders in mice
107. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease
108. Aiolos regulates B cell activation and maturation to effectorstate
109. Homozygous C1q deficiency caused glomerulonephritis associated with multiple apoptotic bodies
110. Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2
111. Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b
112. Hyperresponsive B cells in CD22-deficient mice
113. Features of systemic lupus erythematosus in Dnase 1-deficient mice
114. Spontaneous autoimmune disease in FcgammaRIIB-deficient mice results from strain-specific epistasis
115. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase(Hcph) gene
116. Motheaten and viable motheaten mice have mutations in the hematopoietic cell phosphatase genes
117. + T cells
118. Interleukin-2 receptor chain regulates the size and content of the peripheral lymphoid compartment
119. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor
120. Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice
121. Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease
122. Serum amyloid P component controls chromatin degradation and prevent antinuclear autoimmunity
123. Activation and accumulation of B cells in TACI-deficient mice
124. SLE-like autoantibodies and Sjogren's syndrome-like lymphoproliferation in TGF-beta knockout mice
125. Development of lupus-like autoimmune disease by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor
126. Autoimmune dilatated cardiomyopathy in PD-1 receptor-deficient mice
127. Inhibitory signaling by B cell FcgammaRIIb
128. Polymorphisms in IgG Fc receptor IIB regulatory regions associated with autoimmune susceptibility
129. CD22, a B lymphocyte specific adhesion molecule that regulates antigen receptor signaling
130. Dysregulated expression of the CD22 gene as a result of a short interspersed nucleotide element insertion in CD22a lupus-prone mice
131. Deregulated Bcl-2-immunoglobulin transgene expands a resting but responsive immunoglobulin M and D-expressing B-cell population
132. Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus
133. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms